REMdesivir-HU Clinical Study and Severe Covid-19 Patients

Clinical trial NCT04610541 · UNKNOWN

Trial details

NCT number: NCT04610541
Sponsor: University of Pecs
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

SARS-CoV-2 Infection

Start date: 2020-10-12
Primary completion: 2021-10-30
Enrollment: 2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.